Results 11 to 20 of about 18,613 (204)
Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors [PDF]
In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address this issue, we systematically reviewed the literature.
Simone Janett +7 more
doaj +4 more sources
Hypomagnesemia in type 2 diabetes mellitus
Introduction: Hypomagnesemia is reported in type 2 diabetes; magnesium deficiency may play a role in the development of endothelial dysfunction and altered insulin function.
Arundhati Dasgupta +2 more
doaj +2 more sources
An overview of diagnosis and management of drug‐induced hypomagnesemia [PDF]
Magnesium (Mg) is commonly addressed as the “forgotten ion” in medicine. Nonetheless, hypomagnesemia should be suspected in clinical practice in patients with relevant symptomatology and also be considered a predisposing factor for the development of ...
George Liamis +3 more
doaj +2 more sources
Analysis of patients with hypomagnesemia using the Japanese Adverse Drug Event Report database (JADER) [PDF]
Summary – Purpose. In order to clarify the occurrence of hypomagnesemia in Japan, we conducted a database search and analysis using the Japanese Adverse Drug Event Report database (JADER). Methods. Among the cases recorded in JADER between April 2004 and
Hiroyuki Tanaka +4 more
doaj +2 more sources
Hypomagnesemia and hypermagnesemia
Introduction: Magnesium is an essential element which also has pleiotropic effects in humans. Recent studies have altered our interpretation of a disturbed magnesium balance both leading to hypomagnesemia and hypermagnesemia.
Steven Van Laecke, Van Laecke, Steven
core +3 more sources
Association of hypomagnesemia with hypocalcemia after thyroidectomy
Background: Hypocalcemia is one of the most common acceptable complications in postoperative period after thyroidectomy. Hypomagnesemia has been recognized after parathyroid surgery, and it has not been studied extensively after thyroidectomy. The aim of
Shrikanth P Chincholikar, Sudha Ambiger
doaj +2 more sources
Iatrogenic hypomagnesemia: an underestimated clinical problem
Hypomagnesemia is defined by having a serum magnesium level of less than 1.7 mg/dL. The magnesium balance is tightly regulated by the concerted actions of the intestine, bone and kidneys. This balance can be disturbed by a wide variety of drugs. Recently,
Antonio Villa +6 more
doaj +2 more sources
Hypomagnesemia: a clinical perspective
Phuong-Chi T Pham,1 Phuong-Anh T Pham,2 Son V Pham,3 Phuong-Truc T Pham,4 Phuong-Mai T Pham,5 Phuong-Thu T Pham61Olive View–UCLA Medical Center, Los Angeles, CA, USA; 2Veterans Administration Central California Health Care System, Fresno, CA, USA ...
Pham PT +4 more
core +5 more sources
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. [PDF]
BackgroundAlthough many case reports have described patients with proton pump inhibitor (PPI)-induced hypomagnesemia, the impact of PPI use on hypomagnesemia has not been fully clarified through comparative studies.
Chan Hyuk Park +4 more
doaj +2 more sources
Background:We assessed the effects of cisplatin-based chemotherapy, magnesium supplementation, probable contributory factors such as cisplatin cumulative dose and dose per cycle on serum magnesium levels.
Marjaneh Mirsadraee +2 more
doaj +1 more source

